Genomic medicine in the Middle East and North Africa (MENA) lags due to underrepresentation in genomic datasets despite the region's unique medical needs and available talent. Arab populations face higher rates of recessive disorders and diseases like heart disease and diabetes, but limited regional data hampers diagnosis, risk prediction, and treatment personalization. Although sequencing costs have fallen and infrastructure improvements like AI-enabled cloud analysis offer new opportunities, lack of coordination and fragmented research efforts across 22 countries prevent effective collaboration. Empowering young scientists and building shared genomic infrastructure are critical to enhancing regional genomic sovereignty and equitable healthcare outcomes.
ICT,Health
Africa
12 October 2026
AI4AI
A World Economic Forum Initiative